Jennison Associates LLC Novo Nordisk A S Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
A detailed history of Jennison Associates LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jennison Associates LLC holds 18,822,002 shares of NVO stock, worth $1.26 Billion. This represents 0.93% of its overall portfolio holdings.
Number of Shares
18,822,002
Previous 19,944,809
5.63%
Holding current value
$1.26 Billion
Previous $1.72 Billion
23.82%
% of portfolio
0.93%
Previous 1.06%
Shares
25 transactions
Others Institutions Holding NVO
# of Institutions
1,763Shares Held
340MCall Options Held
11.4MPut Options Held
15.5M-
Bank Of America Corp Charlotte, NC14.8MShares$988 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$827 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$823 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$793 Million0.36% of portfolio
-
Fayez Sarofim & CO Houston, TX11.2MShares$749 Million2.01% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $151B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...